Sullivan, Bruyette, Speros & Blaney’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$1.78M Sell
6,457
-3
-0% -$775 0.08% 78
2020
Q4
$1.69M Buy
6,460
+145
+2% +$34.8K 0.08% 77
2020
Q3
$1.43M Sell
6,315
-106
-2% -$24.3K 0.08% 78
2020
Q2
$1.38M Sell
6,421
-521
-8% -$98.5K 0.08% 78
2020
Q1
$1.13M Hold
6,942
0.08% 77
2019
Q4
$1.46M Buy
6,942
+32
+0.5% +$6.24K 0.08% 72
2019
Q3
$1.33M Buy
6,910
+500
+8% +$96.8K 0.08% 69
2019
Q2
$1.18M Buy
6,410
+271
+4% +$48.7K 0.07% 74
2019
Q1
$1.08M Buy
6,139
+757
+14% +$119K 0.07% 73
2018
Q4
$759K Buy
5,382
+534
+11% +$84.5K 0.05% 86
2018
Q3
$825K Hold
4,848
0.07% 67
2018
Q2
$793K Buy
4,848
+297
+7% +$46.2K 0.08% 64
2018
Q1
$699K Buy
4,551
+125
+3% +$19.8K 0.07% 70
2017
Q4
$678K Buy
+4,426
New +$641K 0.06% 75

Other funds holding ACN

Sullivan, Bruyette, Speros & Blaney's ACN Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney reduced its Accenture (ACN) stake by 0.05% in Q1 2021, selling an estimated $775 and leaving 6,457 shares worth $1.78M. The position accounts for 0.08% of the portfolio, ranked #78.

Sullivan, Bruyette, Speros & Blaney first reported a position in ACN in Q4 2017 and has held it in 14 quarters since. 1,833 funds tracked by Wall St. Rank hold ACN as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 6,457 shares of Accenture worth $1.78M as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney sold 3 Accenture shares in Q1 2021, an estimated $775.
  • Accenture made up 0.08% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #78 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Accenture in Q4 2017 and has held it in 14 quarters since.
  • 1,833 funds tracked by Wall St. Rank held Accenture as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.